TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Reviva Bio AB
Closing information (x1000 DKK)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
26,376
|
11,680
|
7,752 |
| Financial expenses |
76
|
4
|
0 |
| Earnings before taxes |
5,310
|
920
|
779 |
| EBITDA |
5,935
|
984
|
834 |
| Total assets |
15,678
|
8,274
|
4,491 |
| Current assets |
10,824
|
8,064
|
4,310 |
| Current liabilities |
4,556
|
4,116
|
951 |
| Equity capital |
8,137
|
3,688
|
3,078 |
| - share capital |
34
|
32
|
33 |
| Employees (average) |
19
|
11
|
8 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
51.9%
|
44.6%
|
68.5% |
| Turnover per employee |
1,388
|
1,062
|
969 |
| Profit as a percentage of turnover |
20.1%
|
7.9%
|
10.0% |
| Return on assets (ROA) |
34.4%
|
11.2%
|
17.3% |
| Current ratio |
237.6%
|
195.9%
|
453.2% |
| Return on equity (ROE) |
65.3%
|
24.9%
|
25.3% |
| Change turnover |
13,856
|
4,207
|
895 |
| Change turnover % |
111%
|
56%
|
13% |
| Chg. No. of employees |
8
|
3
|
0 |
| Chg. No. of employees % |
73%
|
38%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.